Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.
Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.
复制标题
15(R)-15-甲基前列腺素 E2(阿巴前列素)对十二指肠溃疡愈合的影响:一项双盲多中心研究。
DOI:
10.1016/s0016-5085(82)80328-4
复制
发表时间:
1982
期刊:
影响因子:
29.4
通讯作者:
A. Robert
中科院分区:
文献类型:
--
作者:
G. Vantrappen;J. Janssens;T. Popiela;J. Kulig;G. Tytgat;K. Huibregtse;R. Lambert;J. Pauchard;A. Robert
A multicenter study was conducted on 173 patients with active, endoscopically proven duodenal ulcers (158 men, 15 women). They were randomly assigned, in a double-blind manner, to two groups: those receiving placebo capsules (91 patients) and those receiving capsules containing 100 μg of 15(R)15-methyl prostaglandin E2(arbaprostil) (82 patients). Each drug was ingested four times a day (1 h before meals and at bedtime) for 28 days. Endoscopy was performed on days 0, 14, and 28 after the trial began. At each examination, the ulcer size was measured and whether the ulcer had healed was recorded. Arbaprostil increased the incidence of ulcer healing to approximately the same degree as reported in most extensive studies with cimetidine.